Get started
Author

Adi Joseph Klil-Drori

Observed names: A J Klil-Drori, A. Klil-Drori, A.J. Klil-Drori, Adi J Klil-Drori, Adi J. Klil-Drori, Adi J. Klil‐Drori, Adi Klil-Drori, Klil-Drori, Adi
Observed institutions: Sunnybrook Health Science Centre, Technion – Israel Institute of Technology, University of Toronto, Rambam Health Care Campus, Jewish General Hospital, Sunnybrook Hospital, Lady Davis Institute for Medical Research, AbbVie Canada (Canada), Odette Cancer Centre, McGill University
ORCID: 0000-0001-9368-7953
Observed ORCID: 0000-0001-9368-7953
OpenAlex ID: A5089124222
Cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing?
2016 · Adi J. Klil-Drori, Laurent Azoulay, et al. · Nature Reviews Clinical Oncology · 212
Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism
2018 · Susan R Kahn, David R Morrison, et al. · Cochrane Database of Systematic Reviews · 99
PDF
Exercise Intervention for Late-Life Depression: A Meta-Analysis
2020 · Sivan Klil-Drori, Adi J. Klil-Drori, et al. · The Journal of Clinical Psychiatry · 59
Androgen Deprivation Therapy for Prostate Cancer and the Risk of Venous Thromboembolism
2015 · Adi J. Klil-Drori, Hui Yin, et al. · European Urology · 51
15-Lipoxygenases in cancer: A double-edged sword?
2013 · Adi J. Klil-Drori, Amiram Ariel · Prostaglandins & Other Lipid Mediators · 51
Direct Oral Anticoagulants in End-Stage Renal Disease
2018 · Vicky Tagalakis, Adi Klil-Drori · Seminars in Thrombosis and Hemostasis · 29
PDF
Androgen Deprivation Therapy and the Risk of Anemia in Men with Prostate Cancer
2017 · Blánaid M. Hicks, Adi J. Klil-Drori, et al. · Epidemiology · 29
Effectiveness of interventions for the implementation of thromboprophylaxis in hospitalised patients at risk of venous thromboembolism: an updated abridged Cochrane systematic review and meta-analysis of randomised controlled trials
2019 · Susan R Kahn, Gisele Diendéré, et al. · BMJ Open · 27
PDF
Evaluation of a Telephone Version for the Montreal Cognitive Assessment: Establishing a Cutoff for Normative Data From a Cross-Sectional Study
2021 · Sivan Klil-Drori, Natalie Phillips, et al. · Journal of Geriatric Psychiatry and Neurology · 25
Temporal trends in outpatient management of incident pulmonary embolism and associated mortality
2017 · Adi J. Klil-Drori, Janie Coulombe, et al. · Thrombosis Research · 24
Activation of coagulation in amniotic fluid during normal human pregnancy
2011 · Galit Sarig, Adi J. Klil-Drori, et al. · Thrombosis Research · 23
Androgen Deprivation Therapy and the Incidence of Inflammatory Bowel Disease in Patients With Prostate Cancer
2016 · Adi J. Klil-Drori, Koray Tascilar, et al. · American Journal of Epidemiology · 21
PDF
Persistence with generic imatinib for chronic myeloid leukemia: a matched cohort study
2019 · Adi J. Klil-Drori, Hui Yin, et al. · Haematologica · 13
PDF
External Validation of ASPECT (Algorithm for Suspected Pulmonary Embolism Confirmation and Treatment)
2019 · Adi J. Klil-Drori, Dwip Prajapati, et al. · Medical Care · 9
Screening women at high risk for breast cancer: one program fits all?
2020 · Naama Hermann, Adi Klil-Drori, et al. · Breast Cancer Research and Treatment · 8
Prolactin-Elevating Antipsychotics and the Risk of Endometrial Cancer
2017 · Adi J. Klil-Drori, Hui Yin, et al. · The Journal of Clinical Psychiatry · 8
Serum organochlorines and non-Hodgkin lymphoma: A case-control study in Israeli Jews and Palestinians
2018 · Adi J. Klil-Drori, Geffen Kleinstern, et al. · Chemosphere · 7
PDF
Early switch to second‐line tyrosine kinase inhibitor in chronic myeloid leukemia patients failing to achieve early molecular response
2017 · Adi J. Klil‐Drori, Hui Yin, et al. · American Journal of Hematology · 5
PDF
Comparative Effectiveness of Generic Imatinib and Brand-Name Imatinib for the Treatment of Chronic Myeloid Leukemia
2015 · Adi J Klil-Drori, Laurent Azoulay, et al. · Blood · 4
Molecular monitoring of therapeutic milestones and clinical outcomes in patients with chronic myeloid leukemia
2018 · Adi J. Klil‐Drori, Hui Yin, et al. · Cancer · 3
PDF
Comparative Risk of Acute Kidney Injury with Oral Anticoagulant Use Among Patients with Nonvalvular Atrial Fibrillation
2017 · Adi J. Klil-Drori, Laurent Azoulay, et al. · Blood · 3
Statins in Multiple Myeloma: Survival Benefit or Immortal Time Bias?
2017 · Samy Suissa, Adi J. Klil-Drori · Journal of Clinical Oncology · 3
The Risk of Major Bleeding with Low-Molecular-Weight-Heparins for Venous Thromboembolism in Dialysis Patients: The Q-VTE Study
2016 · Adi J. Klil-Drori, Janie Coulombe, et al. · Blood · 3
The Role of Selection in the Risk of Bleeding With Dabigatran in Patients With Atrial Fibrillation
2015 · Adi Klil-Drori, Laurent Azoulay · JAMA Internal Medicine · 3
Management and use of healthcare resources in patients with chronic lymphocytic leukemia initiating venetoclax in routine clinical practice
2024 · Versha Banerji, Andrew Aw, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2
Works count: 44
Citation count: 729
H-index: 13
I10-index: 13
Year
Topic
Type